You are here

Prices & Quotes - UK Markets - AstraZeneca (AZN)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
7,380.00p
Change Today:
0.000p
Market Cap:
96,880m
Sector:
Pharmaceuticals & Biotechnology

FDA to review AstraZeneca and FibroGen's Roxadustat

By Iain Gilbert

Date: Tuesday 02 Mar 2021

LONDON (ShareCast) - (Sharecast News) - Pharmaceutical giant AstraZeneca said on Tuesday that the Food and Drug Administration will convene a meeting of its Cardiovascular and Renal Drugs Advisory Committee to review a new US drug application for Roxadustat.
Roxadustat, AstraZeneca's collaborative effort with American firm FibroGen, has been under regulatory review for the treatment of anaemia of chronic kidney disease, with the meeting following a move by the FDA in December to extend the review period in order to carry out further analysis of data.

The drug has already been approved to treat anaemia in chronic kidney disease in non-dialysis dependent and dialysis-dependent adults patients in China, Japan and Chile and is also under regulatory review in the EU.

As of 0850 GMT, AstraZeneca shares were down 0.64% at 6,935.0p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AstraZeneca Market Data

Currency UK Pounds
Price 7,380.00p
Change Today 0.000p
52 Week High 9,320.00p
52 Week Low 6,794.00p
Volume 0
Shares Issued 1,312.74m
Market Cap 96,880m

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. half market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector
Price Trend
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Income
market
  1. full market star
  2. full market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector
Growth
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. half market star
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. half sector star
Price Chg 6m
market
  1. half market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
P/E
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
PEG
market
  1. half market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Dividend Yield
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. empty sector
EPS Growth
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. half market star
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. full sector star
Operating Margin
market
  1. full market star
  2. full market star
  3. full market star
  4. half market star
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. empty sector

What The Brokers Say

Strong Buy 21
Buy 2
Neutral 3
Sell 0
Strong Sell 1
Total 27
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 25-Feb-21 13-Aug-20
Paid 29-Mar-21 14-Sep-20
Amount 190.00¢ 90.00¢

Trades

No recent trades found

AstraZeneca Key Personnel